Home/Propanc Biopharma/James Nathanielsz
JN

James Nathanielsz

Chief Executive Officer, Managing Director

Propanc Biopharma

Therapeutic Areas

Propanc Biopharma Pipeline

DrugIndicationPhase
PRPAdvanced Solid Tumors (Pancreatic, Ovarian)Phase 1/2